- Home
- SPGC vs ALZN Comparison
SPGC vs ALZN Comparison
Compare SPGC & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPGC
- ALZN
- Stock Information
- Founded
- SPGC 2018
- ALZN 2016
- Country
- SPGC United States
- ALZN United States
- Employees
- SPGC N/A
- ALZN N/A
- Industry
- SPGC
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- SPGC
- ALZN Health Care
- Exchange
- SPGC Nasdaq
- ALZN Nasdaq
- Market Cap
- SPGC 7.4M
- ALZN 6.9M
- IPO Year
- SPGC 2023
- ALZN 2021
- Fundamental
- Price
- SPGC $2.04
- ALZN $1.64
- Analyst Decision
- SPGC
- ALZN
- Analyst Count
- SPGC 0
- ALZN 0
- Target Price
- SPGC N/A
- ALZN N/A
- AVG Volume (30 Days)
- SPGC 139.3K
- ALZN 361.1K
- Earning Date
- SPGC 11-07-2024
- ALZN 12-13-2024
- Dividend Yield
- SPGC N/A
- ALZN N/A
- EPS Growth
- SPGC N/A
- ALZN N/A
- EPS
- SPGC N/A
- ALZN N/A
- Revenue
- SPGC $1,375,000.00
- ALZN N/A
- Revenue This Year
- SPGC $771.92
- ALZN N/A
- Revenue Next Year
- SPGC $76.31
- ALZN N/A
- P/E Ratio
- SPGC N/A
- ALZN N/A
- Revenue Growth
- SPGC 530.73
- ALZN N/A
- 52 Week Low
- SPGC $1.59
- ALZN $1.40
- 52 Week High
- SPGC $11.29
- ALZN $33.00
- Technical
- Relative Strength Index (RSI)
- SPGC 36.18
- ALZN 40.84
- Support Level
- SPGC $1.62
- ALZN $1.58
- Resistance Level
- SPGC $3.97
- ALZN $1.90
- Average True Range (ATR)
- SPGC 0.26
- ALZN 0.14
- MACD
- SPGC -0.15
- ALZN 0.05
- Stochastic Oscillator
- SPGC 18.91
- ALZN 39.53
About SPGC Sacks Parente Golf Inc.
Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.